Angiopoietin-1 is essential in mouse vasculature during development and in response to injury

被引:373
作者
Jeansson, Marie [1 ]
Gawlik, Alexander [2 ]
Anderson, Gregory [3 ]
Li, Chengjin [1 ]
Kerjaschki, Dontscho [4 ]
Henkelman, Mark [3 ]
Quaggin, Susan E. [1 ,5 ,6 ]
机构
[1] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M4T 2Y4, Canada
[2] Rheinisch Westfal Tech Hsch RWTH Univ Aachen, Aachen, Germany
[3] Toronto Ctr Phenogen, Mouse Imaging Ctr, Toronto, ON, Canada
[4] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria
[5] Univ Toronto, St Michaels Hosp, Div Nephrol, Toronto, ON M4T 2Y4, Canada
[6] Univ Toronto, Dept Med, Univ Hlth Network, Toronto, ON M4T 2Y4, Canada
关键词
ENDOTHELIAL GROWTH-FACTOR; BLOOD-VESSELS; DIABETIC-NEPHROPATHY; TIE2; RECEPTOR; STEM-CELLS; ANGIOGENESIS; MICE; EXPRESSION; VEGF; COMP-ANGIOPOIETIN-1;
D O I
10.1172/JCI46322
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Angiopoietin-1/Tek signaling is a critical regulator of blood vessel development, with conventional knockout of angiopoietin-1 or Tek in mice being embryonically lethal due to vascular defects. In addition, angiopoietin-1 is thought to be required for the stability of mature vessels. Using a Cre-Lox conditional gene targeting approach, we have studied the role of angiopoietin-1 in embryonic and adult vasculature. We report here that angiopoietin-1 is critical for regulating both the number and diameter of developing vessels but is not required for pericyte recruitment. Cardiac-specific knockout of angiopoietin-1 reproduced the phenotype of the conventional knockout, demonstrating that the early vascular abnormalities arise from flow-dependent defects. Strikingly, deletion in the entire embryo after day E13.5 produced no immediate vascular phenotype. However, when combined with injury or microvascular stress, angiopoietin-1 deficiency resulted in profound organ damage, accelerated angiogenesis, and fibrosis. These findings redefine our understanding of the biological roles of angiopoietin-1: it is dispensable in quiescent vessels but has a powerful ability to modulate the vascular response after injury.
引用
收藏
页码:2278 / 2289
页数:12
相关论文
共 43 条
[21]   COMP-angiopoietin-1 ameliorates renal fibrosis in a unilateral ureteral obstruction model [J].
Kim, Won ;
Moon, Sang-Ok ;
Lee, Sang Yong ;
Jang, Kyu Yun ;
Cho, Chung-Hyun ;
Koh, Gou Young ;
Choi, Kyu-Sil ;
Yoon, Kwon-Ha ;
Sung, Mi Jeong ;
Kirn, Duk Hoon ;
Lee, Sik ;
Kang, Kyung Pyo ;
Park, Sung Kwang .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (09) :2474-2483
[22]   Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes [J].
Lee, Sik ;
Kim, Won ;
Moon, Sang-Ok ;
Sung, Mi Jeong ;
Kim, Duk Hoon ;
Kang, Kyung Pyo ;
Jang, Kyu Yoon ;
Lee, Sang Yong ;
Park, Byung Hyun ;
Koh, Gou Young ;
Park, Sung Kwang .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (02) :396-408
[23]   Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes - Implications for cardiovascular in risk and effects of multifactorial intervention [J].
Lim, HS ;
Blann, AD ;
Chong, AY ;
Freestone, B ;
Lip, GYH .
DIABETES CARE, 2004, 27 (12) :2918-2924
[24]   A highly efficient recombineering-based method for generating conditional knockout mutations [J].
Liu, PT ;
Jenkins, NA ;
Copeland, NG .
GENOME RESEARCH, 2003, 13 (03) :476-484
[25]  
Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO
[26]  
2-B
[27]   Abnormal Angiogenesis in Diabetic Nephropathy [J].
Nakagawa, Takahiko ;
Kosugi, Tomoki ;
Haneda, Masakazu ;
Rivard, Christopher J. ;
Long, David A. .
DIABETES, 2009, 58 (07) :1471-1478
[28]  
Partanen J, 1999, CURR TOP MICROBIOL, V237, P159
[29]   TRANSFORMING GROWTH-FACTOR TYPE-BETA - RAPID INDUCTION OF FIBROSIS AND ANGIOGENESIS INVIVO AND STIMULATION OF COLLAGEN FORMATION INVITRO [J].
ROBERTS, AB ;
SPORN, MB ;
ASSOIAN, RK ;
SMITH, JM ;
ROCHE, NS ;
WAKEFIELD, LM ;
HEINE, UI ;
LIOTTA, LA ;
FALANGA, V ;
KEHRL, JH ;
FAUCI, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (12) :4167-4171
[30]   Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties [J].
Satchell, SC ;
Anderson, KL ;
Mathieson, PW .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (03) :566-574